In animal models, the expression of CEBPD altered in skeletal and muscular functions and overexpression of the dominant negative CEBPD protein results in fibrosis, cardiac hypertrophy, and dilated cardiomyopathy 29, 30, 31. The gene discussed is CEBPD; the disease is dilated cardiomyopathy.